Head and Neck Diseases by Alexandros G.Sfakianakis: Ipilimumab (New Therapeutic Indication) -- Benefit Assessment According to §35a Social Code Book V [Internet].

Παρασκευή 16 Ιουνίου 2017

Ipilimumab (New Therapeutic Indication) -- Benefit Assessment According to §35a Social Code Book V [Internet].

The aim of this report was to assess the added benefit of ipilimumab compared with dacarbazine as appropriate comparator therapy (ACT) in adult patients with advanced (unresectable or metastatic) melanoma who have not received prior therapy to treat advanced melanoma.

http://ift.tt/2siOrba

Head and Neck Diseases by Alexandros G.Sfakianakis

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Παρασκευή 16 Ιουνίου 2017

Ipilimumab (New Therapeutic Indication) -- Benefit Assessment According to §35a Social Code Book V [Internet].

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου